论文部分内容阅读
康莱特注射乳剂（ＫＬＴ）是新近研制成功的一种新型中药制剂，基础和临床研究表明对于多种肿瘤具有一定的疗效。ＭＵＣ１粘蛋白（ＭＵＣ１）是一种在上皮性肿瘤高度和异常表达的膜糖蛋白，与肿瘤的侵袭、转移、预后及易感性等密切相关［１］，并可参与肿瘤细胞的信号传导［２
KLT is a newly developed traditional Chinese medicine preparation. Basic and clinical studies have shown that it has a certain curative effect on many kinds of tumors. MUC1 mucin (MUC1) is a membrane glycoprotein that is highly and abnormally expressed in epithelial tumors and is closely related to tumor invasion, metastasis, prognosis, and susceptibility [1] and may be involved in signal transduction in tumor cells [2]